The results showed that in gastric cancer, RORA expression was positively correlated with the expression of NRP1, CD40, CD276, CD86, HHLA2, CD160, TNFSF4, TNFSF18, TNFRSF8, CD244, TNFSF9, CD70, TNFSF14, VTCN1, HAVCR2, CD27, TNFRSF14, ICOS, LGALS9, CD28, TIGIT, TNFRSF4, IDO2, and PDCD1LG2, while it was negatively correlated with LAG3 expression. This evidence concerns the gene CD160 and gastric cancer.